Tag: Mild traumatic brain injury
ATAI Life Sciences partners with Neuronasal to develop concussion treatment
ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More
Prevacus to use blinktbi’s EyeStat in phase 1 concussion drug trial
Clinical trial news : US biopharma company Prevacus has forged a partnership with medical device company blinktbi to use the latter’s EyeStat as an objective ... Read More